[CAS NO. 1255517-76-0]  PF-4708671

Ships within Stock Price Qty Total
$0.00
$0.00
Please click "REQUEST A QUOTE" button if you need other sizes or custom synthesis
request a quote
If there is no stock, or you need other sizes or custom synthesis, please:

PRODUCTS SPECIFICATIONS [1255517-76-0]

Store
Catalog
SLK-S2163
Brand
Selleck
CAS
1255517-76-0

DESCRIPTION [1255517-76-0]

Overview

MDLMFCD18086922
Molecular Weight390.41
Molecular FormulaC19H21F3N6
SMILESFC(C1=CC=C2C(NC(CN3CCN(C4=NC=NC=C4CC)CC3)=N2)=C1)(F)F

For research use only.

Storage

3 years,-20°C,powder
1 years,-80°C,in solvent

Shipping

Room temperature shipping(Stability testing shows this product can be shipped without any cooling measures.)

Preparing Stock Solutions

1 mg5 mg10 mg
1 mM2.5614 mL12.8070 mL25.6141 mL
5 mM0.5123 mL2.5614 mL5.1228 mL
10 mM0.2561 mL1.2807 mL2.5614 mL
50 mM0.0512 mL0.2561 mL0.5123 mL

Description

PF-4708671 is a cell-permeable inhibitor of (S6K1 isoform) with / of 20 nM/160 nM in cell-free assays, 400-fold greater selectivity for S6K1 than S6K2, and 4- and >20-fold selectivity for S6K1 than MSK1 and RSK1/2, respectively. PF-4708671 induces autophagy. First S6K1-specific inhibitor to be reported.

Targets

p70 S6K1 [1]
(Cell-free assay)
160 nM

In vitro

PF-4708671 is a piperazinyl-pyrimidine analogue and the first S6K1-specific inhibitor. PF-4708671 does not significantly inhibit the activity of the closely related S6K2 isoform or a number of other AGC kinases (Akt1, Akt2, PKA, PKCα, PKCϵ, PRK2, ROCK2, RSK1, RSK2 or SGK1) . PF-4708671 prevents the S6K1-mediated phosphorylation of S6 protein in response to IGF-1 (insulin-like growth factor 1), while having no effect upon the PMA-induced phosphorylation of substrates of the highly related RSK (p90 ribosomal S6 kinase) and MSK (mitogen- and stress-activated kinase) kinases. PF-4708671 is also found to induce phosphorylation of the T-loop and hydrophobic motif of S6K1, an effect that is dependent upon mTORC1 (mTOR complex 1). PF-4708671 does not affect activity of mTORC1.